Abstract:Protein synthesis regulation is critical for skeletal muscle hypertrophy, yet other established cellular processes are necessary for growth-related cellular remodeling. Autophagy has a well-acknowledged role in muscle quality control, but evidence for its role in myofiber hypertrophy remains equivocal. Both mammalian target of rapamycin complex I (mTORC1) and bone morphogenetic protein (BMP)-Smad1/5 (Sma and Mad proteins from Caenorhabditis elegans and Drosophila, respectively) signaling are reported regulators of myofiber hypertrophy; however, gaps remain in our understanding of how this regulation is integrated with growth processes and autophagy regulation. Therefore, we investigated the mTORC1 and Smad1/5 regulation of protein synthesis and autophagy flux during serum-stimulated myotube growth. Chronic serum stimulation experiments were performed on day 5 differentiated C2C12 myotubes incubated in differentiation medium [2% horse serum (HS)] or growth medium [5% fetal bovine serum (FBS)] for 48 h. Rapamycin or LDN193189 was dosed for 48 h to inhibit mTORC1 and BMP-Smad1/5 signaling, respectively. Acute serum stimulation was examined in day 7 differentiated myotubes. Protein synthesis was measured by puromycin incorporation. Bafilomycin A1 and immunoblotting for LC3B were used to assess autophagy flux. Chronic serum stimulation increased myotube diameter 22%, total protein 21%, total RNA 100%, and Smad1/5 phosphorylation 404% and suppressed autophagy flux. Rapamycin, but not LDN193189, blocked serum-induced myotube hypertrophy and the increase in total RNA. Acute serum stimulation increased protein synthesis 111%, Smad1/5 phosphorylation 559%, and rpS6 phosphorylation 117% and suppressed autophagy flux. Rapamycin increased autophagy flux during acute serum stimulation. These results provide evidence for mTORC1, but not BMP-Smad1/5, signaling being required for serum-induced myotube hypertrophy and autophagy flux by measuring LC3BII/I expression. Further investigation is warranted to examine the role of autophagy flux in myotube hypertrophy.NEW & NOTEWORTHY The present study demonstrates that myotube hypertrophy caused by chronic serum stimulation requires mammalian target of rapamycin complex 1 (mTORC1) signaling but not bone morphogenetic protein (BMP)-Smad1/5 signaling. The suppression of autophagy flux was associated with serum-induced myotube hypertrophy and mTORC1 regulation of autophagy flux by measuring LC3BII/I expression. Rapamycin is widely investigated for beneficial effects in aging skeletal muscle and sarcopenia; our results provide evidence that rapamycin can regulate autophagy-related signaling during myotube growth, which could benefit skeletal muscle functional and metabolic health.

Insulin-Like Growth Factor I-Mediated Skeletal Muscle Hypertrophy Is Characterized By Increased Mtor-P70s6k Signaling Without Increased Akt Phosphorylation

Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy

IGF-II Transcription in Skeletal Myogenesis is Controlled by Mtor and Nutrients.

IGF-1 Signaling Regulates Mitochondrial Remodeling during Myogenic Differentiation

Focal adhesion kinase is required for IGF-I-mediated growth of skeletal muscle cells via a TSC2/mTOR/S6K1-associated pathway.

Insulin-like Growth Factor-1 (IGF-1) and Leucine Activate Pig Myogenic Satellite Cells Through Mammalian Target of Rapamycin (mtor) Pathway.

Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass

IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway

IGF-II-mediated Downregulation of Peroxisome Proliferator-Activated Receptor-Γ Coactivator-1Α in Myoblast Cells Involves PI3K/Akt/FoxO1 Signaling Pathway

Acute Myotube Protein Synthesis Regulation by IL-6-related Cytokines.

Differential activation of mTOR signaling by contractile activity in skeletal muscle

Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation.

Insulin-like Growth Factor-1 Receptor is Regulated by Microrna-133 During Skeletal Myogenesis.

Incorporation of a Skeletal Muscle-Specific Enhancer in the Regulatory Region of Igf1 Upregulates IGF1 Expression and Induces Skeletal Muscle Hypertrophy

IGF-1 Potentiates Sensory Innervation Signalling by Modulating the Mitochondrial Fission/fusion Balance

Interactions Between P-Akt and Smad3 in Injured Muscles Initiate Myogenesis or Fibrogenesis

Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21.

mTOR/p70s6k signaling pathway and muscle protein synthesis induced by exercise

Focal adhesion kinase is required for IGF-1-mediated growth of skeletal 1 muscle cells via a TSC 2-mTOR-S 6 K 1-associated pathway 2

The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy

mTORC1 and BMP-Smad1/5 regulation of serum-stimulated myotube hypertrophy: a role for autophagy